As a result, the correct Figure 2 and its accompanying legend appear below.
Colour coding represents the degree of activation (shades of red), or suppression (shades of blue) versus that region in the control larvae, relative to other brain regions within that treatment group. The treatment group shown is that at which the highest activity was observed, which was the top concentration for 4AP, pilocarpine and strychnine, but 2.5 mM (the second highest) for PTZ due to a slight dip in neural activity at the highest treatment level. Colour coding in the left most column represents anatomical categorisation as subdivisions of the telencephalon, diencephalon, mesencephalon and rhombencephalon, along with ganglia (green) respectively from top to bottom. n/a -values not obtained due to a failure in registration probably due to the high z-depth of this region. N = 8 larvae were imaged per group. For corresponding SEM values, see Supplementary Table 3 .
Scientific REPORts | For illustrative purposes only partial example profiles for a PTZ-exposed (red) and control fish (blue) are shown and the various parameters highlighted on these traces. (C) Peak profile analysis data for each region across treatments. The treatment group shown is that at which the highest activity was observed (Top concentrations for 4AP, pilocarpine and strychnine, and 2.5 mM for PTZ due to a slight dip in neural activity at the highest treatment level) Each data point is the mean across all fish/treatment group expressed as the % change versus the mean of the corresponding control group (F1−F0)/F0*100, where F1=treated group value, and F0=control group value. Note that for the AUC and the peak height profiles, 4AP data were divided by 10 to allow plotting on the same axis. Data also summarised in Supplementary Figure 5 .
Scientific REPORts | . Example concentration response curves generated for selected brain regions of interest in fish exposed to each of the 4 drugs. To provide representative curves, all data shown are those derived from measurements of mean peak fluorescence intensity across all larvae within that treatment group, except pilocarpine noradrendergic (NA) neurons of the interfascicular and vagal areas for which the AUC is presented (divided by 10 to allow plotting on the same axis) and all of the strychnine data (peak separation data shown). Data are shown as the average of the median fluorescence intensity measures obtained for each fish in that treatment group, ±SEM (n = 7-8). All statistical analyses were undertaken using a Kruskal Wallis analysis across treatment groups, followed by a Dunn's post-hoc test in which each drug-treated group was compared with the corresponding control group. *Denotes significance at the P < 0.05, and **at the P < 0.01 level in order of lines on graph. Strychnine significance levels are shown below each point in order of the legend. For full concentration-response datasets please see Supplementary Table 5. 
